GLADE MICHEL WIRTZ advises consortium led by ABACON on acquisition of CustomCells Group out of insolvency

GLADE MICHEL WIRTZ provided comprehensive legal advice to the consortium of buyers led by lead investor ABACON on the acquisition of the CustomCells Group out of insolvency. The transaction lays the foundation for the long-term continuation of the company at its headquarters in Itzehoe.

CustomCells Group is one of Europe's most innovative suppliers in the development and manufacture of high-performance battery cells for demanding industrial applications. Its customers include companies from the defense and security, aviation, motorsport and mining sectors – NATO system integrators, for example, already purchase qualified cells for the navy. The parties have agreed not to disclose the details of the transaction or the purchase price.

Following the insolvency of air taxi manufacturer Lilium, CustomCells Group's main customer, CustomCells was forced to also file for insolvency in April 2025. Business operations at CustomCells in Itzehoe had been continued in preliminary insolvency proceedings since the end of April 2025 by insolvency administrator Dr Malte Köster (law firm WILLMERKÖSTER) and his team. Insolvency proceedings were opened on 1 July 2025. The sales process was successfully completed just one day later.

In addition to ABACON, other family offices were also involved in the transaction as investors, including SALVIA. The investors' stated goal is to maintain and further develop the established production site in Itzehoe.